Definitely. And from my Twitter stream, there seem to be quite a few who were initially elated with the results but managed to sell quickly after hours and then buy back after it fell.
All in all, I think Dew's point about AMD being multi-focal and not overly amenable to a single gene therapy is very relevant.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.